Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), bought 260 shares at $38.00 ($10K) on 2010-10-07, disclosed to the SEC on 2010-10-12.
Open-market purchase of $10k SLXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |